Cite
HARVARD Citation
Kabeshova, A. et al. (n.d.). Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. Therapeutic advances in gastroenterology. pp. 473-482. [Online].